Tachyarrhythmia
📧 Sign up to get email alerts when something new happens for Tachyarrhythmia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs [NA]
The update discusses a study evaluating the Eko Digital Stethoscope's ability to capture infant ECGs for tachyarrhythmias and is currently r…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: BIO|MASTER.CorSky Family Post-market Study for the CorSky Family of ICDs
This is an update for a post-market study evaluating Biotronik's CorSky family of implantable cardioverter-defibrillators, which is not yet …
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Lead Evaluation for Defibrillation and Reliability Post Approval Study
Medtronic is conducting a post-approval study to evaluate the reliability of a defibrillation lead. The study is currently enrolling by invi…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP) [NA]
The LEADR and LEADR LBBAP clinical trials evaluating defibrillation lead performance and reliability in left bundle branch area pacing have …
-
FDA approval · 2025-06-11FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for metoprolol tartrate (Hospira, Inc.), a generic beta-blocker, confirming continued approval of th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Post Market Clinical Follow-up Study for the Pamira ICD Lead Family [NA]
Post-market clinical follow-up study of the Pamira ICD Lead Family by Biotronik has completed, evaluating long-term safety and performance i…
-
FDA approval · 2024-11-07FDA Approved: ESMOLOL HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for Esmolol Hydrochloride (generic) from Mylan Institutional LLC.
-
FDA approval · 2024-10-15FDA Approved: ESMOLOL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA supplemental approval for Amneal's esmolol hydrochloride in sodium chloride, a generic injectable product.
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: Master Study of the Acticor/Rivacor ICDs/CRT-Ds and the Plexa ProMRI S DX Lead [NA]
Completed clinical trial update for Biotronik's Acticor ICDs and Rivacor CRT-Ds with the Plexa ProMRI S DX Lead; results have been posted.
-
FDA approval · 2024-07-11FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for propranolol hydrochloride by Lannett Company, Inc., approving changes to the existing ANDA to su…
-
FDA approval · 2024-07-09FDA Approved: ESMOLOL HYDROCHLORIDE — Supplemental Application (Eugia US LLC)
The FDA approved a supplemental application for esmolol hydrochloride in sodium chloride (Esmolol Hydrochloride in Sodium Chloride) filed by…
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: Master Study of the BIOMONITOR III and Incision and Insertion Tool (FIT OneStep) [NA]
Completed Master Study of Biotronik's BIOMONITOR III with the FIT OneStep incision/insertion tool; results were posted in January 2024.
-
FDA approval · 2022-03-21FDA Approved: ESMOLOL HYDROCHLORIDE — Original Application (Eugia US LLC)
FDA approved the original application for esmolol hydrochloride in sodium chloride injection, a generic product manufactured by Eugia US LLC…
-
FDA approval · 2019-10-30FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for metoprolol tartrate by Hospira, Inc. under ANDA 078085, finalizing changes to the generic produc…
-
FDA approval · 2019-08-14FDA Approved: ESMOLOL HYDROCHLORIDE — Original Application (Gland Pharma Limited)
The FDA approved the original abbreviated application for esmolol hydrochloride from Gland Pharma Limited, confirming a generic esmolol hydr…
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: BIO|MASTER.Ilivia Family / Plexa [NA]
Completed clinical trial update for BIO|MASTER.Ilivia Family / Plexa; results posted in 2019 for conditions including heart failure and tach…
-
FDA approval · 2018-06-08FDA Approved: ESMOLOL HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)
FDA approved esmolol hydrochloride injection as an original generic application from Sagent Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Safety and Clinical Performance of the Protecta ICD and CRT-D [NA]
A completed clinical trial evaluated the safety and clinical performance of the Protecta ICD and CRT-D devices. Results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Full Automaticity and Remote Follow-up
A Medtronic-sponsored trial evaluating full automaticity and remote follow-up for tachyarrhythmia management has completed, with results pos…
-
CLINICAL_TRIALS trial_result · 2015-07-15Clinical Trial Update: Iperia/Sentus QP Study
Clinical trial update for the Iperia/Sentus QP study completed by Biotronik, evaluating heart failure and tachyarrhythmia indications.
-
FDA approval · 2015-01-26FDA Approved: BREVIBLOC — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for Brevibloc (esmolol hydrochloride) submitted by Baxter Healthcare Corporation.
-
CLINICAL_TRIALS trial_result · 2009-06-10Clinical Trial Update: ConsultaTM CRT-D Clinical Evaluation Study [NA]
Completed results of Medtronic's ConsultaTM CRT-D Clinical Evaluation Study evaluating the device in patients with tachyarrhythmias and hear…
-
FDA approval · 2007-06-21FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for propranolol hydrochloride (generic) from Hikma Pharmaceuticals USA Inc., indicating an approval …
-
CLINICAL_TRIALS trial_result · 2006-11-22Clinical Trial Update: ASSURE Study - Arrhythmia Single Shock DFT Versus ULV: Risk Reduction Evaluation With ICD Implantations [Phase 4]
Phase 4 ASSURE trial evaluating risk reduction with a single-shock defibrillation threshold strategy versus ultra-low energy in patients wit…